CANY
CELL

Caxton Associates (New York)’s PhenomeX Inc. Common Stock CELL Stock Holding History

Caxton Associates (New York)’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100,824
Closed -$270K – 661
2022
Q4 		$270K Buy
100,824
+82,324
+445% +$221K 0.02% 324
2022
Q3 		$53K Buy
+18,500
New +$53K 0.01% 442